Nanocapsulated quercetin downregulates rat hepatic MMP-13 and controls diethylnitrosamine-induced carcinoma

Nanomedicine (Lond). 2014 Oct;9(15):2323-37. doi: 10.2217/nnm.14.11. Epub 2014 Mar 5.

Abstract

Aims: The aims of our work were to investigate the controlling role and the efficacy of nanocapsulated quercetin drug delivery system on the decrement of inflammatory mediators such as MMP-13 in diethyl nitrosamine (DEN)-induced hepatocarcinogenesis.

Materials & methods: Hepatocellular carcinoma was developed in the Swiss albino rats by the exposure of DEN. DEN administration caused the generation of reactive oxygen species, upregulation of TNF-α, IL-6, activation of MMP-13, severe oxidative damage, hyperplastic nodules with preneoplastic lesions and the histopathological changes in rat liver.

Results & conclusion: Nanocapsulated quercetin treatment restricted all alterations in DEN-mediated development of hepatocarcinogenesis. Therefore, it may be concluded that nanocapsulated quercetin may be accepted as a potent therapeutic formulation in preventing DEN-mediated hepatocarcinogenesis.

Keywords: MMP-13; diethyl nitrosamine; hepatocarcinogenesis; nanocapsulated quercetin; proinflammatory cytokines; reactive oxygen species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diethylnitrosamine / toxicity*
  • Down-Regulation / drug effects*
  • Liver / drug effects*
  • Liver / enzymology
  • Liver Neoplasms, Experimental / chemically induced
  • Liver Neoplasms, Experimental / prevention & control*
  • Male
  • Matrix Metalloproteinase 13 / metabolism*
  • Microscopy, Atomic Force
  • Microscopy, Electron, Transmission
  • Nanocapsules*
  • Quercetin / pharmacology*
  • Rats

Substances

  • Nanocapsules
  • Diethylnitrosamine
  • Quercetin
  • Matrix Metalloproteinase 13